Related Experiment Video
Updated: Nov 9, 2025

Identifying Coronary Artery Calcification on Non-gated Computed Tomography Scans
Published on: August 28, 2018
Prognostic implications of cardiac damage classification based on computed tomography in severe aortic stenosis
Kensuke Hirasawa1, Philippe J vanRosendael1, Federico Fortuni1,2
1Department of Cardiology, Heart Lung Centre, Leiden University Medical Centre, Albinusdreef 2, 2300 RC Leiden, The Netherlands.
Insights
A new Multidetector Row Computed Tomography (MDCT) staging system for severe aortic stenosis (AS) identifies patients at higher risk of death after transcatheter aortic valve implantation (TAVI). This system assesses extra-valvular cardiac damage to improve patient stratification and outcomes.
Area of Science:
- Cardiology
- Radiology
- Medical Imaging
Background:
- Severe aortic stenosis (AS) management often involves transcatheter aortic valve implantation (TAVI).
- Prognosis after TAVI can be influenced by extra-valvular cardiac damage.
- Echocardiography has established staging systems for AS prognosis, but MDCT offers detailed anatomical assessment.
Purpose of the Study:
- To evaluate the prognostic implications of a Multidetector Row Computed Tomography (MDCT) staging system for severe AS.
- To assess the ability of MDCT to detect and classify extra-valvular cardiac damage in AS patients undergoing TAVI.
- To determine if this MDCT staging system can identify patients at higher risk of mortality post-TAVI.
Main Methods:
- A cohort of 405 patients undergoing pre-TAVI MDCT for severe AS was analyzed.
- Cardiac damage was assessed using MDCT and categorized into five stages (0-4) based on the extent of extra-valvular involvement.
- Patient outcomes, including all-cause mortality, were tracked over a median follow-up of 3.7 years.
Main Results:
- The study included 405 patients (80±7 years, 52% male).
- Patients were classified into MDCT stages: Stage 0 (7%), Stage 1 (24%), Stage 2 (38%), Stage 3 (19%), and Stage 4 (13%).
- Multivariable analysis revealed that Stage 3 (HR 4.496, P=0.039) and Stage 4 (HR 5.565, P=0.020) cardiac damage were independently associated with increased all-cause mortality post-TAVI.
Conclusions:
- The MDCT-based staging system for cardiac damage in severe AS is effective in identifying patients with a higher risk of mortality after TAVI.
- This imaging-based approach provides valuable prognostic information beyond traditional AS assessment.
- MDCT staging can aid in risk stratification and personalized treatment planning for TAVI candidates.
Aims:
An echocardiographic staging system of severe aortic stenosis (AS) based on additional extra-valvular cardiac damage has been associated with prognosis after transcatheter aortic valve implantation (TAVI). Multidetector row computed tomography (MDCT) is key in the evaluation of AS patients undergoing TAVI and can potentially detect extra-valvular cardiac damage. This study aimed at evaluating the prognostic implications of an MDCT staging system of severe AS in patients undergoing TAVI.
Methods And Results:
A total of 405 patients (80 ± 7 years, 52% men) who underwent full-beat MDCT prior to TAVI were included. The extent of cardiac damage was assessed by MDCT and classified in five categories; Stage 0 (no cardiac damage), Stage 1 (left ventricular damage), Stage 2 (left atrium and mitral valve damage), Stage 3 (right atrial damage), and Stage 4 (right ventricular damage). Twenty-seven (7%) patients were stratified as Stage 0, 96 (24%) as Stage 1, 152 (38%) as Stage 2, 78 (19%) as Stage 3, and 52 (13%) as Stage 4. During a median follow-up of 3.7 (IQR 1.7-5.5) years, 150 (37%) died. On multivariable Cox regression analysis, cardiac damage Stage 3 (HR vs. Stage 0: 4.496, P = 0.039) and Stage 4 (HR vs. Stage 0: 5.565, P = 0.020) were independently associated with all-cause mortality.
Conclusion:
The MDCT-based staging system of cardiac damage in severe AS effectively identifies the patients who are at higher risk of death after TAVI.
More Related Videos
06:46Quantitative Micro-CT Analysis of Aortopathy in a Mouse Model of β-aminopropionitrile-induced Aortic Aneurysm and Dissection
Published on: July 16, 2018
06:51Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research
Published on: October 20, 2023
Related Concept Videos
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Aortic Regurgitation I: Introduction
Imaging Studies for Cardiovascular System V: CT
Mitral Stenosis II: Clinical features and Diagnostic Tests